Literature DB >> 15545822

Histocompatibility leukocyte antigen-D related expression is specifically altered and predicts mortality in septic shock but not in other causes of shock.

Vincent Caille1, Jean-Daniel Chiche, Noureddine Nciri, Christine Berton, Sébastien Gibot, Bernadette Boval, Didier Payen, Jean-Paul Mira, Alexandre Mebazaa.   

Abstract

Although the expression of monocyte histocompatibility leukocyte antigen (HLA)-DR has been shown to be decreased during human sepsis, its level of expression in other nonseptic critical conditions is unclear. The aim of this study was to compare the level of HLA-DR expression on circulating monocytes among patients with septic, hemorrhagic, and cardiogenic shocks and severe sepsis without shock. At admission, HLA-DR expression was exclusively decreased in patients with septic shock (n = 30; P < 0.001), whereas the expression was similar between the other studied groups: cardiogenic shock (n = 16), hemorrhagic shock (n = 11), severe sepsis without shock (n = 18), and healthy volunteers (n = 8). HLA-DR expression was not predictive for overall mortality, but at day 1, an HLA-DR expression of less than 14 of mean fluorescence intensity (that corresponds to 40% labeled monocytes) was predictive of mortality exclusively in patients with septic shock (odds ratio, 11.4 and 95% confidence interval, 1.7; 78.4; P < 0.008). Catecholamine infusion, mechanical ventilation, positive blood culture, and number of units of blood or plasma transfused did not correlate with decreased HLA-DR expression. Thus, the decrease in HLA-DR expression is specific to septic shock and is associated, in septic shock patients, with increased mortality risk.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15545822     DOI: 10.1097/01.shk.0000143410.63698.57

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  17 in total

1.  Measurement of monocytic HLA-DR (mHLA-DR) expression in patients with severe sepsis and septic shock: assessment of immune organ failure.

Authors:  Joerg C Schefold
Journal:  Intensive Care Med       Date:  2010-07-23       Impact factor: 17.440

Review 2.  The three human monocyte subsets: implications for health and disease.

Authors:  Kok Loon Wong; Wei Hseun Yeap; June Jing Yi Tai; Siew Min Ong; Truong Minh Dang; Siew Cheng Wong
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

3.  Profound and persistent decrease of circulating dendritic cells is associated with ICU-acquired infection in patients with septic shock.

Authors:  D Grimaldi; S Louis; F Pène; G Sirgo; C Rousseau; Y E Claessens; L Vimeux; A Cariou; J P Mira; A Hosmalin; J D Chiche
Journal:  Intensive Care Med       Date:  2011-07-30       Impact factor: 17.440

4.  Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock.

Authors:  Caroline Landelle; Alain Lepape; Nicolas Voirin; Eve Tognet; Fabienne Venet; Julien Bohé; Philippe Vanhems; Guillaume Monneret
Journal:  Intensive Care Med       Date:  2010-07-23       Impact factor: 17.440

Review 5.  [Special aspects of abdominal sepsis].

Authors:  S Maier; T Traeger; A Westerholt; C-D Heidecke
Journal:  Chirurg       Date:  2005-09       Impact factor: 0.955

6.  Gene profiling in human blood leucocytes during recovery from septic shock.

Authors:  Didier Payen; Anne-Claire Lukaszewicz; Ioulia Belikova; Valérie Faivre; Catherine Gelin; Stefan Russwurm; Jean-Marie Launay; Nicolas Sevenet
Journal:  Intensive Care Med       Date:  2008-04-05       Impact factor: 17.440

7.  CRISPLD2 is expressed at low levels during septic shock and is associated with procalcitonin.

Authors:  Tao Wang; Zhi-qin Wang; Lv Wang; Li Yan; Jian Wan; Sheng Zhang; Hong-quan Jiang; Wen-fang Li; Zhao-fen Lin
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

8.  Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful association to predict the development of sepsis after major trauma.

Authors:  Aurélie Gouel-Chéron; Bernard Allaouchiche; Caroline Guignant; Fanny Davin; Bernard Floccard; Guillaume Monneret
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

9.  Extracorporeal cell therapy of septic shock patients with donor granulocytes: a pilot study.

Authors:  Jens Altrichter; Martin Sauer; Katharina Kaftan; Thomas Birken; Doris Gloger; Martin Gloger; Jörg Henschel; Heiko Hickstein; Ernst Klar; Sebastian Koball; Annette Pertschy; Gabriele Nöldge-Schomburg; Dierk A Vagts; Steffen R Mitzner
Journal:  Crit Care       Date:  2011-03-03       Impact factor: 9.097

10.  Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis.

Authors:  Holger Poehlmann; Joerg C Schefold; Heidrun Zuckermann-Becker; Hans-Dieter Volk; Christian Meisel
Journal:  Crit Care       Date:  2009-07-15       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.